AI专家 (AI药物设计)/AI Expert (AIDD)(博士)当面告知

百濟神州有限公司
2026-12-15 15:28:34
校招博士27届

岗位详情

地区:

北京
·
上海

专业要求:

计算机科学与技术

岗位职责:

Role Overview We are seeking a highly motivated Ph.D. expert with a profound scientific background in computational chemistry/biology and exceptional AI/ML skills to join our AI Drug Discovery (AIDD) team. The successful candidate will focus on advancing computational and AI-driven approaches for Antibody-Drug Conjugates (ADCs), specifically leading linker design, pharmacokinetic (PK) prediction and multi-parameters optimization. In this role, you will work closely with cross-functional teams (Biologics, Medicinal Chemistry and DMPK) to accelerate the discovery of differentiated ADC candidates. ________________________________________ Key Responsibilities 1. Advancing AI & Computational Methodologies for ADCs • ADC PK Prediction: Develop hybrid AI and mechanistic PK models (PBPK, QSP, compartment modeling) to predict ADC pharmacokinetic profiles, including clearance, half-life, plasma/circulation stability, cleavage kinetics and deconjugation rates. • Linker-Payload Design & Multi-Parameter Optimization: Develop generative AI models, physics-based simulations, and computational frameworks for de novo Linker-Payload design, site-specific conjugation design, and structure-property relationship (SPR) modeling. 2. Cross-Functional Pipeline Enablement • Targeted Project Support: Deploy bespoke AI/CADD solutions to address project-specific bottlenecks in ongoing ADC campaigns, accelerating linker-payload pairing, candidate selection, and optimization. • Cross-Disciplinary Synergy: Collaborate closely with Biologics, ADC Chemistry, and DMPK teams to integrate experimental data feedback loops into AI model training and iterative molecule design. ________________________________________ Qualifications Education & Scientific Fundamentals • Ph.D. in Computational Chemistry, Cheminformatics, Computational Biology, Pharmacometrics/PKPD Modeling, Computer Science (AI/ML for Life Sciences), or a related field. • Demonstrated track record in developing and deploying AIDD or computational methods in drug discovery and molecular modeling (evidenced by high-impact publications, patents, thesis research, or pipeline implementations) in at least one of the following areas (prior experience in ADCs or bioconjugates is a strong bonus): • Computational Linker & Small Molecule Generation: Expertise in computational linker design, scaffold hopping, de novo molecular generation, or multiparameter lead optimization (experience in ADC linkers or bioconjugates is a plus). • AI Antibody Design & Engineering for PK/PD: Expertise in AI/computational antibody/protein design, binder optimization, or protein engineering targeted at optimizing biophysical and PK/PD properties (e.g., stability, clearance, Fc/FcRn engineering) (experience in ADCs or therapeutic antibodies is a plus). • Small Molecule ADMET Prediction: Strong track record in developing machine learning/deep learning models for small molecule ADMET property prediction, clearance, or quantitative structure-activity/property relationships (QSAR/QSPR) (experience in ADC payloads/linkers or PK/PD modeling is a plus). Technical & Engineering Skills • Proficient in Python, with extensive experience using cheminformatics/structural biology libraries (e.g., RDKit, OpenBabel, OpenMM, PyMOL). • Expertise in deep learning frameworks (PyTorch, TensorFlow) and relevant architectures (GNNs, Generative Models, Diffusion Models, Transformers) applied to molecular or ADME/PK tasks. • Strong software engineering practices with the ability to lead the design, implementation, and maintenance of robust AI platforms. • Familiarity with CADD tools (molecular docking, MD simulations) or PK/PD modeling tools (e.g., Simcyp, PK-Sim, NONMEM, Julia/SciML) is a plus. Soft Skills • Fast Learner: Ability to quickly absorb experimental assay nuances, track cutting-edge ADC industry advancements, and understand translational drug workflows. • Independent Research: Strong capability to independently tackle complex, multidisciplinary R&D challenges at the intersection of chemistry, biology, and data science. • Communication: Excellent cross-disciplinary communication skills, capable of translating algorithmic and ML models into actionable chemical, DMPK, and biological insights. ________________________________________ Preferred Qualifications • Open to fresh Ph.D. graduates with exemplary doctoral publications/thesis OR candidates with 1–3+ years of biotech/pharma industry or post-doc experience directly supporting ADC or bioconjugate drug discovery pipelines. • Demonstrated experience in building computational PK/PD or machine learning models for ADME/PK prediction in small molecules or biologics. • Experience in developing integrated AI tool platforms for drug discovery teams.

招聘要求:

Role Overview We are seeking a highly motivated Ph.D. expert with a profound scientific background in computational chemistry/biology and exceptional AI/ML skills to join our AI Drug Discovery (AIDD) team. The successful candidate will focus on advancing computational and AI-driven approaches for Antibody-Drug Conjugates (ADCs), specifically leading linker design, pharmacokinetic (PK) prediction and multi-parameters optimization. In this role, you will work closely with cross-functional teams (Biologics, Medicinal Chemistry and DMPK) to accelerate the discovery of differentiated ADC candidates. ________________________________________ Key Responsibilities 1. Advancing AI & Computational Methodologies for ADCs • ADC PK Prediction: Develop hybrid AI and mechanistic PK models (PBPK, QSP, compartment modeling) to predict ADC pharmacokinetic profiles, including clearance, half-life, plasma/circulation stability, cleavage kinetics and deconjugation rates. • Linker-Payload Design & Multi-Parameter Optimization: Develop generative AI models, physics-based simulations, and computational frameworks for de novo Linker-Payload design, site-specific conjugation design, and structure-property relationship (SPR) modeling. 2. Cross-Functional Pipeline Enablement • Targeted Project Support: Deploy bespoke AI/CADD solutions to address project-specific bottlenecks in ongoing ADC campaigns, accelerating linker-payload pairing, candidate selection, and optimization. • Cross-Disciplinary Synergy: Collaborate closely with Biologics, ADC Chemistry, and DMPK teams to integrate experimental data feedback loops into AI model training and iterative molecule design. ________________________________________ Qualifications Education & Scientific Fundamentals • Ph.D. in Computational Chemistry, Cheminformatics, Computational Biology, Pharmacometrics/PKPD Modeling, Computer Science (AI/ML for Life Sciences), or a related field. • Demonstrated track record in developing and deploying AIDD or computational methods in drug discovery and molecular modeling (evidenced by high-impact publications, patents, thesis research, or pipeline implementations) in at least one of the following areas (prior experience in ADCs or bioconjugates is a strong bonus): • Computational Linker & Small Molecule Generation: Expertise in computational linker design, scaffold hopping, de novo molecular generation, or multiparameter lead optimization (experience in ADC linkers or bioconjugates is a plus). • AI Antibody Design & Engineering for PK/PD: Expertise in AI/computational antibody/protein design, binder optimization, or protein engineering targeted at optimizing biophysical and PK/PD properties (e.g., stability, clearance, Fc/FcRn engineering) (experience in ADCs or therapeutic antibodies is a plus). • Small Molecule ADMET Prediction: Strong track record in developing machine learning/deep learning models for small molecule ADMET property prediction, clearance, or quantitative structure-activity/property relationships (QSAR/QSPR) (experience in ADC payloads/linkers or PK/PD modeling is a plus). Technical & Engineering Skills • Proficient in Python, with extensive experience using cheminformatics/structural biology libraries (e.g., RDKit, OpenBabel, OpenMM, PyMOL). • Expertise in deep learning frameworks (PyTorch, TensorFlow) and relevant architectures (GNNs, Generative Models, Diffusion Models, Transformers) applied to molecular or ADME/PK tasks. • Strong software engineering practices with the ability to lead the design, implementation, and maintenance of robust AI platforms. • Familiarity with CADD tools (molecular docking, MD simulations) or PK/PD modeling tools (e.g., Simcyp, PK-Sim, NONMEM, Julia/SciML) is a plus. Soft Skills • Fast Learner: Ability to quickly absorb experimental assay nuances, track cutting-edge ADC industry advancements, and understand translational drug workflows. • Independent Research: Strong capability to independently tackle complex, multidisciplinary R&D challenges at the intersection of chemistry, biology, and data science. • Communication: Excellent cross-disciplinary communication skills, capable of translating algorithmic and ML models into actionable chemical, DMPK, and biological insights. ________________________________________ Preferred Qualifications • Open to fresh Ph.D. graduates with exemplary doctoral publications/thesis OR candidates with 1–3+ years of biotech/pharma industry or post-doc experience directly supporting ADC or bioconjugate drug discovery pipelines. • Demonstrated experience in building computational PK/PD or machine learning models for ADME/PK prediction in small molecules or biologics. • Experience in developing integrated AI tool platforms for drug discovery teams.

公司介绍

百濟神州有限公司

百濟神州有限公司

百濟神州有限公司,成立于2018-06-28,位于香港,登记状态:仍注册,注册资本15.4142万美元,公司类型:中外合资

百济神州有限公司是一家商业化阶段的生物技术公司,专注于开发及商业化用于治疗癌症的创新型分子靶向及肿瘤免疫治疗药物。百济神州拥有广泛全面的产品组合。其产品包括六种内部开发、临床阶段的候选药物,其中包括三种后期临床候选药物,zanubrutinib(BTK抑制剂),tislelizumab(PD-1抗体)与pamiparib(PARP抑制剂)。百济神州亦获得五种药物及在研药物的授权许可,包括三种已于中国销售的由新基独家授权的药物ABRAXANE、REVLIMID 及VIDAZA,及两种临床阶段的在研药物,该种药物已获得于中国及亚太地区的其他指定国家开发及商业化的权利。百济神州于2010年于北京成立并在2016年2月在美国纳斯达克全球精选市场上市。截至2018年7月,公司拥有一支超过1300名员工的全球团队,成为一家拥有涵盖研究、临床开发、生产及商业化的全面实力的全球生物技术公司。